John SiekierkaWarminster, PA

John Siekierka Phones & Addresses

Warminster, PA

Work

Company: Virtua Marlton Address: 90 Brick Road, Marlton, NJ 08053

Education

School / High School: Philadelphia College Of Osteopathic Medicine 1988

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Emergency Medicine

Mentions for John Siekierka

Career records & work history

Medicine Doctors

John Siekierka Photo 1

Dr. John I Siekierka, Marlton NJ - DO (Doctor of Osteopathic Medicine)

Specialties:
Emergency Medicine
Address:
90 Brick Rd, Marlton, NJ 08053
(856) 355-6760 (Phone) (856) 355-6061 (Fax)
Certifications:
Emergency Medicine
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
90 Brick Rd, Marlton, NJ 08053
Virtua Marlton
90 Brick Road, Marlton, NJ 08053
Education:
Medical School
Philadelphia College Of Osteopathic Medicine
Graduated: 1988

John I. Siekierka

Specialties:
Urgent Care Medicine, Family Medicine
Work:
Atlanticare Urgent Care
3131 Rte 38 STE 14, Mount Laurel, NJ 08054
(856) 866-8700 (phone) (856) 866-1302 (fax)
Atlanticare Urgent Care
255 N Rte 73, West Berlin, NJ 08091
(856) 712-9860 (phone)
Education:
Medical School
Philadelphia College of Osteopathic Medicine
Graduated: 1988
Languages:
English
Description:
Dr. Siekierka graduated from the Philadelphia College of Osteopathic Medicine in 1988. He works in Mount Laurel, NJ and 1 other location and specializes in Urgent Care Medicine and Family Medicine.

License Records

John Ira Siekierka

Licenses:
License #: OT002395T - Expired
Category: Osteopathic Medicine
Type: Graduate Osteopathic Trainee

Publications & IP owners

Us Patents

Antiinflammatory Drug And Delivery Device

US Patent:
6776796, Aug 17, 2004
Filed:
May 7, 2001
Appl. No.:
09/850232
Inventors:
Robert Falotico - Belle Mead NJ
Gregory A. Kopia - Neshanic NJ
Gerard H. Llanos - Stewartsville NJ
John Siekierka - Towaco NJ
Andrew J. Carter - Portland OR
Assignee:
Cordis Corportation - Miami Lakes FL
International Classification:
A61F 206
US Classification:
623 146
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease

US Patent:
8236048, Aug 7, 2012
Filed:
Apr 27, 2004
Appl. No.:
10/833200
Inventors:
Robert Falotico - Belle Mead NJ, US
John Siekierka - Towaco NJ, US
Gerard H. Llanos - Stewartsville NJ, US
Gregory A. Kopia - Hillsborough NJ, US
Andrew J. Carter - Portage MI, US
International Classification:
A61F 2/06
US Classification:
623 142, 623 144, 623 145, 623 146
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease

US Patent:
2002000, Jan 17, 2002
Filed:
May 7, 2001
Appl. No.:
09/850365
Inventors:
Robert Falotico - Belle Mead NJ, US
John Siekierka - Towaco NJ, US
International Classification:
A61B019/00
A61F002/06
US Classification:
623/001210, 623/001150, 623/001380, 128/898000
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Antiproliferative Drug And Delivery Device

US Patent:
2004024, Dec 2, 2004
Filed:
May 24, 2004
Appl. No.:
10/852517
Inventors:
Robert Falotico - Belle Mead NJ, US
Gregory Kopia - Hillsborough NJ, US
Gerard Llanos - Stewartsville NJ, US
John Siekierka - Towaco NJ, US
International Classification:
A61K031/42
US Classification:
604/500000
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease

US Patent:
2005000, Jan 6, 2005
Filed:
Apr 21, 2004
Appl. No.:
10/829044
Inventors:
Robert Falotico - Belle Mead NJ, US
Gregory Kopia - Hillsborough NJ, US
Gerard Llanos - Stewartsville NJ, US
John Siekierka - Towaco NJ, US
International Classification:
A61K038/00
A61K048/00
A61K031/4745
US Classification:
424426000, 514002000, 514044000, 514291000
Abstract:
A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

Pharmaceutical Composition And Method For Treating A Joint-Capsule Arthropathy

US Patent:
2006012, Jun 8, 2006
Filed:
Sep 30, 2005
Appl. No.:
11/239725
Inventors:
Dennis Argentieri - Milford NJ, US
Demetrius Carter - Mount Laurel NJ, US
Laura Brown - Hamilton Square NJ, US
Jeffrey Geesin - Doylestown PA, US
John Siekierka - Towaco NJ, US
Han Cui - Bridgewater NJ, US
International Classification:
A61K 31/728
US Classification:
514054000
Abstract:
A pharmaceutical composition for use in treating a joint-capsule arthropathy comprising an effective amount of one or more of a locally administered, optionally encapsulated therapeutic agent in admixture with a hyaluronic acid delivery vehicle and a method for use thereof in treating a joint-capsule arthropathy by intra-articular injection.

Transdiscal Administration Of Inhibitors Of P38 Map Kinase

US Patent:
2009016, Jun 25, 2009
Filed:
Dec 21, 2007
Appl. No.:
12/005060
Inventors:
Laura J. Brown - Hamilton Square NJ, US
Jeffery C. Geesin - Doylestown PA, US
Carrie H. Fang - Pittstown NJ, US
John J. Siekierka - Towaco NJ, US
Assignee:
DePuy Spine, Inc. - Raynham MA
International Classification:
A61K 39/395
A61K 31/496
A61K 31/4439
A61P 19/00
A61K 35/12
A61K 31/519
US Classification:
4241331, 51425409, 514341, 51425309, 5142591, 424 937
Abstract:
The present invention relates to methods, formulations and kits for administering a p38 MAP kinase inhibitor or other therapeutic agent into an intervertebral disc, such as a diseased disc, for example, for purposes of prevention and treatment of degenerative and other disorders.

Trans-Capsular Administration Of P38 Map Kinase Inhibitors Into Orthopedic Joints

US Patent:
2009016, Jun 25, 2009
Filed:
Dec 21, 2007
Appl. No.:
12/005069
Inventors:
Laura J. Brown - Hamilton Square NJ, US
Jeffery C. Geesin - Doylestown PA, US
Carrie H. Fang - Pittstown NJ, US
John J. Siekierka - Towaco NJ, US
International Classification:
A61K 39/395
A61K 31/4439
A61K 31/496
A61K 35/12
US Classification:
4241581, 514341, 51425309, 51425409, 424 937
Abstract:
The present invention relates to trans-capsularly administering into a diseased joint an inhibitor of p38 MAP kinase or a different therapeutic agent.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.